Aromatase inhibitors for treatment of postmenopausal patients with breast cancer. - Wikidata - awgldk - TriplyDB

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

http://www.wikidata.org/entity/Q35117738

about

Cost-effectiveness of letrozole in the treatment of advanced breast cancer.

P2860

Q43266425-09D67890-9838-40DB-9253-DF7540E400B1

P2860

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

http://www.wikidata.org/entity/Q35117738

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@ast

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@en

type

label

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@ast

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@en

prefLabel

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@ast

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@en

P1433

Q35117738-4882485D-4F9C-40FE-86A3-92229438E260

P1476

Q35117738-EC431F82-464C-429D-9BCD-C67C0BFBE04B

P2093

Q35117738-323D7132-AC40-4703-AE2D-48CF30EC94AF

Q35117738-3EE0792F-4EDE-44F7-B9C7-4737334D1E8F

Q35117738-7956883C-0B47-4134-A829-DCE25688528F

Q35117738-9F828A52-15B6-4698-BE15-D010CDB31DFE

Q35117738-AA70BA64-A466-41BF-9EDC-750AEA6EC97A

Q35117738-B279A5D9-83D7-4A3F-973B-CDABE164690E

P2860

Q35117738-0469AA99-DC45-40AD-B9CE-D2795B10980C

Q35117738-07996B58-442F-42E2-BA38-3CFE2F28A3F2

Q35117738-197C88B7-6B71-461C-947D-9AC67C796C60

Q35117738-28A3C1CB-29D7-4054-AEE2-9CBB8B881534

Q35117738-2B3E1F46-269E-4EAC-9A27-F12A81049E1B

Q35117738-58BB7C1A-6B30-46F2-B20B-6CC500468EDD

Q35117738-5A2D7DAE-8D73-46A9-BF19-B572DC94CB7B

Q35117738-D4B72015-A511-4DE1-8999-767049263874

P304

Q35117738-553A59A6-9EEA-4340-A46E-729C415FF0DC

P31

Q35117738-FC43BBD9-CB78-4AC7-8C2B-E320169EF99F

P356

Q35117738-E55BE6F1-C230-478B-803B-E16C76F24B44

P433

Q35117738-22065BCE-4F5F-4B2B-89A4-07F1F17486FE

P478

Q35117738-8303EF35-CF53-4898-B0DC-3F47583685D6

P577

Q35117738-81DB1635-CC2C-4A37-B195-21EDF2568E2E

P698

Q35117738-951A0CD9-761E-4AEE-A687-C348CD07D865

P356

14737140.3.2.193

P1433

Expert Review of Anticancer Therapy

P1476

Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.

@en

P2093

Seung Jin Kim

http://www.w3.org/2001/XMLSchema#string

Shinzaburo Noguchi

http://www.w3.org/2001/XMLSchema#string

Tetsuya Taguchi

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Tamaki

http://www.w3.org/2001/XMLSchema#string

Yasuo Miyoshi

http://www.w3.org/2001/XMLSchema#string

Yoshio Tanji

http://www.w3.org/2001/XMLSchema#string

P2860

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

Tamoxifen for breast cancer among hysterectomised women.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

P304

193-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.3.2.193

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12722879

http://www.w3.org/2001/XMLSchema#string